NasdaqGS - Nasdaq Real Time Price USD
IDEXX Laboratories, Inc. (IDXX)
440.98
+14.35
+(3.36%)
At close: April 24 at 4:00:00 PM EDT
440.98
0.00
(0.00%)
After hours: April 24 at 7:46:09 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 23,423 | 14 |
| Sales | 13,330 | 3 |
| Net Shares Purchased (Sold) | 10,093 | 17 |
| Total Insider Shares Held | 540.83k | -- |
| % Net Shares Purchased (Sold) | 1.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| UNDERBERG SHARON E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 14, 2025 |
| FENNELL GEORGE Officer | -- | Direct | -- | Feb 14, 2025 |
| MAZELSKY JONATHAN JAY Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
| SMITH MARTIN ALEXANDER Officer | -- | Direct | -- | Feb 14, 2025 |
| UNDERBERG SHARON E General Counsel | Conversion of Exercise of derivative security at price 444.53 per share. | Direct | 60,901 | Feb 14, 2025 |
| LANE MICHAEL J Officer | -- | Direct | -- | Feb 14, 2025 |
| HUNT NIMRATA Officer | -- | Direct | -- | Feb 14, 2025 |
| JOHNSON MICHAEL PERKINS Officer | -- | Direct | -- | Feb 14, 2025 |
| SCHRECK MICHAEL Officer | -- | Direct | -- | Feb 14, 2025 |
| ERICKSON MICHAEL G Officer | -- | Direct | -- | Feb 14, 2025 |
| MCKEON BRIAN P Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
| ERICKSON MICHAEL G Officer | Conversion of Exercise of derivative security at price 67.85 per share. | Direct | 104,760 | Feb 11, 2025 |
| FENNELL GEORGE Officer | Sale at price 462.53 per share. | Direct | 4,618,862 | Feb 10, 2025 |
| FENNELL GEORGE Officer | Conversion of Exercise of derivative security at price 79.54 per share. | Direct | 894,189 | Feb 10, 2025 |
| SZOSTAK MARGARET ANNE Director | Sale at price 465.94 per share. | Indirect | 1,397,835 | Feb 7, 2025 |
| VANDEBROEK SOPHIE V Director | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 27, 2024 |
| VANDEBROEK SOPHIE V Director | Sale at price 420.44 per share. | Direct | 144,630 | Nov 27, 2024 |
| AYERS JONATHAN W Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Sep 6, 2024 |
| SZOSTAK MARGARET ANNE Director | Sale at price 469.37 per share. | Indirect | 234,686 | Sep 6, 2024 |
| SZOSTAK MARGARET ANNE Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Sep 5, 2024 |
| SMITH MARTIN ALEXANDER Officer | -- | Direct | -- | Aug 30, 2024 |
| SCHRECK MICHAEL Officer | -- | Direct | -- | Aug 30, 2024 |
| MAZELSKY JONATHAN JAY Chief Executive Officer | -- | Direct | -- | Aug 5, 2024 |
| MCKEON BRIAN P Chief Financial Officer | -- | Direct | -- | Aug 5, 2024 |
| CLAFLIN BRUCE L Director | Sale at price 540.80 per share. | Direct | 108,160 | May 17, 2024 |
| CLAFLIN BRUCE L Director | Sale at price 540.80 per share. | Direct | 108,160 | May 17, 2024 |
| SZOSTAK MARGARET ANNE Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| BRITT IRENE CHANG Director | -- | Direct | -- | May 6, 2024 |
| VANDEBROEK SOPHIE V Director | -- | Direct | -- | May 6, 2024 |
| COLLINS ASHA S. Director | -- | Direct | -- | May 6, 2024 |
| ESSIG STUART M Director | -- | Direct | -- | May 6, 2024 |
| SZOSTAK MARGARET ANNE Director | -- | Direct | -- | May 6, 2024 |
| AYERS JONATHAN W Director | -- | Direct | -- | May 6, 2024 |
| KINGSLEY LAWRENCE D Director | -- | Direct | -- | May 6, 2024 |
| POLEWACZYK JAMES F Officer | Sale at price 557.94 - 559.33 per share. | Direct | 4,525,596 | Mar 6, 2024 |
| POLEWACZYK JAMES F Officer | Conversion of Exercise of derivative security at price 206.94 - 544.08 per share. | Direct | 3,423,547 | Mar 6, 2024 |
| VANDEBROEK SOPHIE V Director | Sale at price 562.98 per share. | Direct | 790,427 | Mar 5, 2024 |
| VANDEBROEK SOPHIE V Director | Conversion of Exercise of derivative security at price 245.79 per share. | Direct | 345,089 | Mar 5, 2024 |
| MAZELSKY JONATHAN JAY Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| MAZELSKY JONATHAN JAY Chief Executive Officer | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 21, 2024 |
| UNDERBERG SHARON E General Counsel | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 16, 2024 |
| MCKEON BRIAN P Chief Financial Officer | Conversion of Exercise of derivative security at price 206.94 per share. | Direct | 99,952 | Feb 15, 2024 |
| UNDERBERG SHARON E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 14, 2024 |
| HUNT NIMRATA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 14, 2024 |
| FENNELL GEORGE Officer | -- | Direct | -- | Feb 14, 2024 |
| POLEWACZYK JAMES F Officer | -- | Direct | -- | Feb 14, 2024 |
| MAZELSKY JONATHAN JAY Chief Executive Officer | -- | Direct | -- | Feb 14, 2024 |
| SMITH MARTIN ALEXANDER Officer | -- | Direct | -- | Feb 14, 2024 |
| UNDERBERG SHARON E General Counsel | Conversion of Exercise of derivative security at price 560.56 per share. | Direct | 270,751 | Feb 14, 2024 |
| LANE MICHAEL J Officer | -- | Direct | -- | Feb 14, 2024 |
Related Tickers
MTD Mettler-Toledo International Inc.
1,075.00
+2.75%
WAT Waters Corporation
340.70
+1.74%
MEDP Medpace Holdings, Inc.
302.88
+4.25%
TMO Thermo Fisher Scientific Inc.
426.66
-1.15%
IQV IQVIA Holdings Inc.
150.68
+2.46%
DHR Danaher Corporation
196.50
+0.10%
ILMN Illumina, Inc.
77.61
+1.78%
DGX Quest Diagnostics Incorporated
175.87
+1.33%
CRL Charles River Laboratories International, Inc.
115.76
+6.20%
LH Labcorp Holdings Inc.
228.58
+1.98%